Switzerland is running a real-world experiment: instead of letting private companies profit from legal cannabis, several cities are piloting sales through not-for-profit clubs and public health programs designed to track use and steer people toward addiction treatment if needed. The film follows these pilot projects as they weigh legalization against harm reduction, asking whether a drug can be sold legally without turning it into just another commercial product chasing growth. It sets the Swiss model against the wider global push toward legalization, where most jurisdictions have handed the market to for-profit companies, and asks what gets lost when public health takes a back seat to sales figures. Researchers, public health officials, and people involved in running the pilot programs describe what addiction research looks like when it is built into the sales system itself, rather than added on afterward. The film treats the not-for-profit approach as an open question rather than a settled solution, tracking Switzerland's early results as a test case other countries are watching.